Anesthesiology Doctors in Sault Sainte Marie, MI Accepting Medicare

3 Anesthesiology doctors found. Showing 1 - 3

James Joseph Kelly, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 Osborn Blvd, Sault Sainte Marie, MI 49783 Phone: 906-635-4390

Dr. Mark Fender, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 500 Osborn Blvd, Sault Sainte Marie, MI 49783 Phone: 906-635-4390

Dr. Andrew Alshab, MD MPH Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Osborn Blvd, Sault Sainte Marie, MI 49783 Phone: 906-635-4460

News Archive

New (and old) ideas for health care show possibility of savings, improvements

The search for reform models continues, with news reports exploring the Veterans Administration's "government-run health care," Washington State's "reputation for lower-cost, higher-quality health care," and Kaiser Permanente's new money-saving approach to heart attack treatment.

Study finds that higher-frequency electric current stimulation of the spinal cord reduces pain faster

An animal study in the August issue of Anesthesiology suggests that higher-frequency electric current stimulation of the spinal cord reduced pain quicker and better reached nerves not affected by traditionally used frequencies. A higher frequency and intensity controlled pain faster and more effectively, the study found.

Study examines how anxiety sensitivity thwarts efforts of smokers with asthma to quit smoking

A new University of Cincinnati study examines how anxiety sensitivity can thwart the efforts of smokers with asthma to quit smoking. This new direction of research from Alison McLeish, a UC assistant professor of psychology, will be presented on Nov.17, at the 46th annual convention of the Association of Behavioral and Cognitive Therapies (ABCT) in National Harbor, Md.

BARDA invites Aeolus Pharmaceuticals to submit proposal for development of AEOL 10150

Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.

First compound for receptors in schizophrenia and Alzheimer's holds promise

For almost 20 years, pharmacological companies have known that certain compounds that activate two specific CNS receptors, causing them to release the neurotransmitter acetylcholine, are effective in treating the cognitive and motor problems related to both schizophrenia and Alzheimer's disease (AD).

Read more Medical News

› Verified 1 days ago